Business Context and Reporting Period
Company: Retractable Technologies, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 5, 2024
Reporting Period: Event date February 5, 2024; Report signed February 16, 2024.
Key Financial Metrics
This filing is an "Other Events" report (Item 8.01) and does not contain financial statements. The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The material event reported is a voluntary product recall initiated on February 5, 2024.
- Product: EasyPoint Needle, Lot Number K220402.
- Scope: Units shipped within the U.S. between July 20, 2022, and September 20, 2023.
- Volume: 477,600 units shipped into the market.
- Defect: Possible detachment of the needle cannula from the needle holder.
- Risk: Potential for serious injury.
Guidance, Outlook, and Management Commentary
Management Actions:
- Advised customers and distributors to review inventory, segregate, and quarantine affected products.
- Ordered discontinuation of distribution and use of affected products.
- Initiated a return process for remaining inventory.
- A Removal Report was submitted to the U.S. Food and Drug Administration (FDA) on February 9, 2024.
- The Company will continue to work with the FDA regarding the recall.
Investor Verification Checklist
- Verify the total number of units remaining in the supply chain versus those already used or returned.
- Monitor FDA communications for any escalation of the recall classification or additional safety findings.
- Assess potential financial impact on future quarters regarding recall costs, inventory write-offs, and potential liability claims.
- Review subsequent filings for updates on the recall resolution timeline.